Ivermectin, a new candidate therapeutic against SARS-CoV-2/COVID-19

Ivermectin exerts broad-spectrum antiviral activity against several animal and human viruses, including both RNA and DNA viruses. As SARS-CoV-2 is an RNA virus, the antiviral activity of ivermectin may be mediated through the inhibition of importin α/β-mediated nuclear transport of viral proteins. The clinical efficacy and utility of ivermectin in SARS-CoV-2-infected patients are unpredictable at this stage, as we are dealing with a completely novel virus.

Ivermectin, a new candidate therapeutic against SARS-CoV-2/COVID-19
Size: 1.0 MB